An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.

ABSTRACT:

Background

Human papillomavirus (HPV) is a common sexually transmitted infection and the leading cause of cervical cancer. The HPV vaccine is a safe and effective way to prevent HPV infection. In Zambia, the vaccine is given during Child Health Week to girls aged 14 years who are in and out of school in two doses over two years. The focus of this evaluation was to establish the cost to administer a single dose of the vaccine as well as for full immunisation of two doses.

Methods

This work was part of a broader study on assessing HPV programme implementation in Zambia. For HPV costing aspect of the study, with a healthcare provider perspective and reference year of 2020, both top-down and micro-costing approaches were used for financial costing, depending on the cost data sou

SUBMITTER: Simuyemba MC 

PROVIDER: S-EPMC10986043 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature